Arcus funding rates and fees
Updated 2026-10-29 23:52 UTC
Arcus
| Type | Decentralised exchange |
| Perpetual markets | 69 |
| Taker / maker fee, standard tier | 0.022% / 0.000% · Source: Arcus /v1/markets effectiveTakerFeePpm (base tier) |
| Funding intervals | 1 h × 69 |
| Coverage on AfterFees | Watch only |
| Data feed | Live |
Best arbitrage using Arcus
No pair nets a profit at this size right now.
At $10,000 per side, held 7 days, after taker fees, order-book slippage and carry.
Highest funding on Arcus
| Coin | Contract | Rate | Every | Annualised | Open interest |
|---|---|---|---|---|---|
| CPER | CPER-USD | 0.0784% | 1 h | +686.7% | $97.8K |
| DRAM | DRAM-USD | 0.0141% | 1 h | +123.9% | $458.8K |
| HYPE | HYPE-USD | 0.0136% | 1 h | +119.4% | $5.4M |
| MRNA | MRNA-USD | 0.0133% | 1 h | +116.2% | $107.3K |
| INTC | INTC-USD | 0.0123% | 1 h | +107.3% | $451.1K |
| SNDK | SNDK-USD | 0.0103% | 1 h | +90.1% | $2.4M |
| CRCL | CRCL-USD | 0.0070% | 1 h | +61.1% | $460.4K |
| GOOGL | GOOGL-USD | 0.0070% | 1 h | +61.0% | $3.2M |
| MU | MU-USD | 0.0068% | 1 h | +60.0% | $1.1M |
| AMZN | AMZN-USD | 0.0056% | 1 h | +49.1% | $499.7K |
| SLV | SLV-USD | 0.0048% | 1 h | +42.0% | $1M |
| TSLA | TSLA-USD | 0.0037% | 1 h | +32.8% | $580K |
Lowest funding on Arcus
| Coin | Contract | Rate | Every | Annualised | Open interest |
|---|---|---|---|---|---|
| BOT | BOT-USD | -0.1957% | 1 h | −1714.0% | $80.3K |
| GME | GME-USD | -0.0102% | 1 h | −89.7% | $102.1K |
| BNB | BNB-USD | -0.0086% | 1 h | −75.7% | $686.1K |
| USO | USO-USD | -0.0062% | 1 h | −54.3% | $852.3K |
| HOOD | HOOD-USD | -0.0051% | 1 h | −44.8% | $1.3M |
| BABA | BABA-USD | -0.0037% | 1 h | −32.2% | $198.2K |
| ORCL | ORCL-USD | -0.0004% | 1 h | −3.6% | $207.3K |
| QQQ | QQQ-USD | -0.0004% | 1 h | −3.4% | $19.3M |
| AAPL | AAPL-USD | -0.0002% | 1 h | −2.1% | $1.8M |
| MSFT | MSFT-USD | 0.0001% | 1 h | +0.5% | $370.2K |
| AMD | AMD-USD | 0.0005% | 1 h | +4.5% | $442K |
| SPY | SPY-USD | 0.0005% | 1 h | +4.5% | $37.9M |
The method behind every number on AfterFees is published; Pro opens each figure into its line-by-line calculation. Estimates from current data, not investment advice. We never hold funds or trade for you.